What the term postbiotic means

SPARDER's 22 September 2026 Chinese article examines postbiotics as an ingredient-development topic for food and supplement OEM/ODM projects. The 2021 ISAPP consensus statement defines a postbiotic as a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host. This is not a synonym for any killed culture or for an isolated fermentation metabolite. A specific preparation needs its own identity, characterization and evidence.

From ingredient identity to a manufacturable product

For a proposed postbiotic ingredient, the first questions concern the source microorganism and strain, fermentation conditions, inactivation method, final preparation, specification and analytical markers. Evidence for one preparation should not automatically be applied to a different strain, process or finished product. SPARDER's proposed development sequence is: target market, preparation identity, scientific evidence, specification, formula compatibility, dosage-form fit, stability validation and repeatable manufacturing.

Unlike live probiotics, a postbiotic does not have to maintain microbial viability as part of its definition. That may give developers different processing and distribution options, but it does not prove that every preparation withstands heat, acid or long storage. The actual ingredient and finished formula still require process and shelf-life testing.

Where formulation teams can explore

• Powders and solid drinks: assess moisture uptake, dispersibility, flowability, flavour and stability.

• Tablets and hard capsules: assess compression or fill performance, excipient compatibility and specification retention.

• Gummies: assess what remains measurable after the actual temperature, acidity, water and gel-process conditions.

• Oral liquids: assess sedimentation, colour, flavour, pH, microbiological control and package compatibility.

These are development routes, not statements that a particular postbiotic product has already been validated or approved. The chosen food category, ingredient status, permitted amount and claims must be reviewed for each destination market before commercialisation.

FAQ for brand teams

Are postbiotics and probiotics the same?

No. Probiotics are live microorganisms, while the ISAPP postbiotic definition concerns a preparation of inanimate microorganisms and/or their components with a demonstrated health benefit.

Does inactivation alone establish a postbiotic claim?

No. Preparation identity and appropriate evidence matter; neither the name of a strain nor an inactivation step alone demonstrates a benefit for the finished product.

Can one formula be sold across all markets?

No. Ingredient status, category, label and claims may differ by market. A project-specific regulatory assessment is needed.

For a postbiotic concept, contact SPARDER with the target market, ingredient specification, intended format and evidence package.